Financials
Financial year 2022
Gross margin
€ 6 million
▼ 12% vs 2021
Profit
Healthy€ 865,963
▼ 16% vs 2021
Debts
High€ 27.1 million
▲ 57% vs 2021
CellCarta Biosciences from Charleroi, company number BE0661567021, closed financial year 2022 with a result of € 865,963 after tax. For that financial year CellCarta Biosciences recorded a gross margin of € 6 million and equity of € 607,231. Compared with financial year 2021, the result moved from € 1 million to € 865,963. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on February 4, 2025.
What happened at CellCarta Biosciences?
What happened at CellCarta Biosciences in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Maurice Tenney III stepped down as director. NBB
- Anthony Mattacchione stepped down as director. NBB
- David Spaight stepped down as director. NBB
- New annual accounts for financial year 2022: profit of € 865,963 (▼ 16% vs 2021). filed late Source: NBB ↗
- Martin Leblanc stepped down as director. NBB
- Maurice Tenney III became a director. NBB
- Anthony Mattacchione became a director. NBB
- David Spaight became a director. NBB
In short
From € 215,269 profit in 2020 to € 865,963 profit in 2022.
Paid € 3,556 in corporate taxes since 2020.
Best year ever: 2021, with € 1 million profit.
On average € 124,900 of value added per employee in 2022.
A new publication or filing at CellCarta Biosciences? We notify you, reason included.
Follow CellCarta BiosciencesNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2022 annual accounts
Anthony Mattacchione
Director
since 2021 · until 2025
since 2019 · until 2025
Martin Leblanc
Director
since 2019 · until 2023
Maurice Tenney III
Director
since 2023 · until 2026
Establishments
Establishment units
Physical locations of this company
Rue Adrienne Bolland 8 box 2
6041 Charleroi
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
Details
- Company number
- 0661.567.021
- VAT number
- BE 0661.567.021
- Registered office
- Rue Adrienne Bolland 8 bus 2, 6041 Charleroi
- Names & denominations
- CellCarta Biosciences
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 18 August 2016
- Peppol
- Active · Active since 14 Oct 2025
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied